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0022-2836/$ - see front matter © 2010 EIn the UapA uric acid–xanthine permease of Aspergillus nidulans, subtle
interactions between key residues of the putative substrate binding pocket,
located in the TMS8–TMS9 loop (where TMS is transmembrane segment),
and a specificity filter, implicating residues in TMS12 and the TMS1–TMS2
loop, are critical for function and specificity. By using a strain lacking all
transporters involved in adenine uptake (ΔazgA ΔfcyB ΔuapC) and
carrying a mutation that partially inactivates the UapA specificity filter
(F528S), we obtained 28 mutants capable of UapA-mediated growth on
adenine. Seventy-two percent of mutants concern replacements of a single
residue, R481, in the putative cytoplasmic loop TMS10–TMS11. Five
missense mutations are located in TMS9, in TMS10 or in loops TMS1–
TMS2 and TMS8–TMS9. Mutations in the latter loops concern residues
previously shown to enlarge UapA specificity (Q113L) or to be part of a
motif involved in substrate binding (F406Y). In all mutants, the ability of
UapA to transport its physiological substrates remains intact, whereas the
increased capacity for transport of adenine and other purines seems to be
due to the elimination of elements that hinder the translocation of non-
physiological substrates through UapA, rather than to an increase in
relevant binding affinities. The additive effects of most novel mutations
with F528S and allele-specific interactions of mutation R481G (TMS10–
TMS11 loop) with Q113L (TMS1–TMS2 loop) or T526M (TMS12) establish
specific interdomain synergy as a critical determinant for substrate
selection. Our results strongly suggest that distinct domains at both sides
of UapA act as selective dynamic gates controlling substrate access to their
translocation pathway.© 2010 Elsevier Ltd. All rights reserved.Keywords: Aspergillus nidulans; nucleobase ascorbate transporter (NAT)
family; structure–function relationships; uric acidEdited by J. KarnIntroduction
UapA, a high-affinity, high-capacity transporter
for uric acid and xanthine in the filamentous
ascomycete Aspergillus nidulans is one of the most
extensively studied, at the genetic and biochemical
level, solute/H+ symporter.1–3 Chimeric construc-ress:
luorescent protein;
, nucleobase
ading frame.
lsevier Ltd. All rights reservetions with UapC (a kinetically distinguishable UapA
paralogue)4 and randomly selected or rationally
designed mutations, combined with green fluores-
cent protein (GFP)-based fluorescence microscopy
and detailed kinetic analyses of functional mutants
using a collection of purine analogues, have led to
important conclusions concerning structure–func-
tion–specificity relationships in this permease.5–10
Of primary importance are the findings strongly
supporting that the long amphiphilic loop linking
transmembrane segments 8 and 9 (TMS8–TMS9)
contains basic elements of the substrate transloca-
tion pathway.5,7,10 These are reflected in four
irreplaceable amino acid residues (E356, D388,
Q408, N409) and several other residues affectingd.
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(A363, E371, R373, G411, T416, R417). Several of
these critical residues (Q408, N409, G411, T416,
R417) define the so-called NAT (nucleobase ascor-
bate transporter) signature motif (residues 406–417)
present in all UapA homologues constituting the
NAT family.2–4 Kinetic evidence has strongly
suggested that this motif interacts with the imidaz-
ole moiety of xanthine, uric acid or other UapA
ligands.7,11 In this interaction, Q408 could make a
direct H-bond with position N9 or C8=O of
xanthine or uric acid, respectively, whereas N409
seems to be a dynamic element absolutely necessary
for molecular movements associated with transport.
Finally, G411 and T416 are important for narrowing
the specificity of UapA to xanthine and uric acid,
whereas R417 increases the affinity of UapA
specifically for uric acid.7,11 An absolutely necessary
functional role has also been assigned to E356,
whereas the absolute need for D388 seems to be
associated with a structural role rather than a
functional one.10
A second important conclusion concerns three
residues enlarging UapA specificity without affect-
ing its kinetic behavior toward physiological sub-
strates, uric acid and xanthine. These are T526 and
F528 in TMS12 and Q113 in the short putative
extracytoplasmic loop linking TMS1 and TMS2 6,9,10
(see Fig. 1a). A weaker but similar effect on UapA
specificity was also obtained with several rationally
designed mutations along TMS1,10 some of which
can also affect UapA function and turnover.12
Allele-specific interactions and kinetic evidence
have strongly suggested that differential positioning
of TMS1 and TMS12 with respect to the TMS8–
TMS9 region acts as a dynamic filter to allow or
restrict access of different purines to the substrate
binding pocket (discussed also later).10
Interestingly, UapA is probably unique among
NAT homologues of known function with respect to
its high affinity and capacity for uric acid
transport.2,3 All other NAT members of prokaryotes
and fungi show high affinity for either xanthine or
uracil (b10 μΜ) but only moderate (N50 μΜ) or no
affinity for uric acid. The only other NAT member
showing high affinity for uric acid is the maize Lpe1
carrier.12 Interestingly, known mammalian NAT
homologues, which are Na+ rather than H+ sym-
porters, are specific either for nucleobases (uracil
and xanthine mostly) or for L-ascorbate.13,14 How-
ever, none of the characterized bacterial, plant or
fungal NATs can transport ascorbate.2,3 The unique
efficiency for uric acid recognition and transport of
UapA seems to depend on specific synergistic
interdomain interactions that cannot be reproduced
in other NAT members or in chimeric molecules
where TMS1, TMS12 or TMS8–TMS9 of UapA has
been replaced by that of homologous carriers from
fungi (UapC),9 bacteria (YgfO)9 or mammals
(SVCT2) (S. Amillis and G. Diallinas, unpublished
results).
Analogous rationally designed mutations and the
substituted-cysteine accessibility method in theEscherichia coli xanthine permease YgfO, a prototype
bacterial member of the NAT family, have led to
very similar conclusions with respect to the func-
tional role of the TMS8–TMS9 region and in
particular the NAT signature motif and the four
functionally irreplaceable amino acid residues.15–18
However, in line with the finding that fine inter-
domain interactions in NAT carriers are protein-
specific and critical for specificity, none of the
YgfO mutations that correspond to the UapA
specificity mutations has led to a carrier that can
efficiently recognize and transport a purine other
than xanthine.
In this work, we used a novel two-step genetic
approach to isolate UapA versions that can effi-
ciently transport adenine. Our results show that
we obtained mutations defining novel elements of
the UapA specificity/selectivity filter, including a
putative cytoplasm-facing loop. These results are
discussed with respect to the importance of inter-
domain synergy and the role of loops as dynamic
gates at both sides of the transporter in substrate
selection.
Results
Rationale of a novel genetic screen for UapA
mutants able to transport adenine
Based on detailed kinetic analyses of the wild-
type, single and double mutants, we have proposed
a model that rationalizes UapA–substrate
interactions.2,3,10,11 In brief, in the wild type, uric
acid or xanthine enters into the putative substrate
binding pocket, an essential part of which is made
by TMS8–TMS9, and binds to specific residues with
high affinity through two strong H-bonds implicat-
ing N1-H and N9 (xanthine) or N1-H and C8=O
(uric acid) and a weaker bond involving C2=O.
Purines, other than xanthine or uric acid, seem to be
excluded from the wild-type substrate binding
pocket due to steric and/or repulsive forces exerted
by the positioning of specific residues in TMS1, in
the TMS1–TMS2 loop and in TMS12, which thus
collectively act as a molecular filter. All previously
identified UapA residues that affect substrate
binding and transport, and especially those map-
ping in the NAT signature motif, seem to be
involved in interactions with the imidazole moiety
of purines.7,9,10 We still ignore which part of UapA,
or any other NAT member, interacts with the
pyrimidine moiety of purines.
To approach this puzzle, we thought of selecting
UapA mutants that would transport adenine, a
purine that has a distinct pyrimidine moiety
compared with the natural substrates of UapA.
Considering the proposed UapA–substrate interac-
tion model, two genetic modifications on the
permease molecule should be satisfied to acquire
high affinity for adenine: (1) the substrate binding
pocket should be accessible to adenine and (2) an
appropriately positioned residue should interact
Fig. 1. (a) Topology of UapA and specificity mutations. Previously characterized residues affecting UapA function
and/or specificity are marked in red (absolutely necessary for function), pink (affecting transport kinetics and specificity)
or green (affecting specificity but not transport kinetics for physiological substrates). Lighter green signifies milder effects
on UapA specificity. Residues in the TMS8–TMS9 loop (in red) are elements of the putative substrate binding site of
UapA, whereas those in TMS1 and TMS12 (in green) are elements of a specificity filter restricting access of purines other
than uric acid and xanthine to the bona fide substrate site. Mutations isolated in this work are highlighted in blue. R481 is
emphasized in size to denote the high frequency (72%) of mutations concerning this residue. Latin numbers denote
putative TMSs. (b) Growth phenotypes of strains expressing wild-type UapA+ or UapA-F528S (F528S) on purines as sole
nitrogen sources (left panel). A strain with total deletion of the uapA locus (ΔUapA) is also shown as a negative control.
Growth on urea (UR, 5 mM) is used as a control. Purines tested as nitrogen sources include uric acid (UA, 0.5 mM),
adenine (AD, 0.5 and 2 mM) and hypoxanthine (HX, 0.5 and 2 mM). OX is oxypurinol (100 μΜ), a toxic analogue of uric
acid/xanthine that is taken up by UapA. Growth on xanthine has also been tested, and results are identical with those of
UA (not shown). Growth tests were performed at 37 °C and pH 6.8, which are the standard growth conditions of A.
nidulans in the laboratory. Similar results were obtained at 25 °C. Note that UapA expression mediates normal growth on
UA (normal colony growth rate and conidiation typically observed in minimal medium) and partial sensitivity to OX
(reduced colony diameter and lack of conidiation) but cannot support growth on AD or HX. Expression of UapA-F528S
leads to similar UapA+ growth on UA but also confers the ability for growth on high concentrations (2 mM) of AD or HX
and oversensitivity to OX. Strain UapA-F528S was used to select for mutants growing on low AD (0.5 mM)
concentrations. The identity, frequency and topology of mutations isolated are shown in Table 1 and in (a), whereas
growth phenotypes of corresponding mutants on purines are shown in the right panel of (b). Notice that all new mutants
isolated differ from the original strain (UapA-F528S) used for their selection in their ability to grow stronger on AD or HX,
particularly evident at low concentrations of these purines (0.5 mM). (c) Relative 3H-labelled xanthine transport rates of
the new mutants expressed as percentage of initial uptake rates (V) compared with the wild-type (UapA+) rate. Standard
deviations in all experiments were always b20% of the mean values shown.
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Table 1. Topology and frequency of second-site
specificity mutations obtained in mutant UapA-F528S
Amino acid
substitution
Topology
in UapA
Nucleotide
change
Number
obtained
Q113L TMS1–TMS2 loop CAG→CTG 1
F406Y TMS8–TMS9 loop TTT→TAT 1
A441V TMS9 GCT→GTT 1
V463I TMS10 GTC→ATC 2
A469E TMS10 GCG→GAG 3
R481G TMS10–TMS11 loop CGG→GGG 1
R481Q TMS10–TMS11 loop CGG→CAG 14
R481L TMS10–TMS11 loop CGG→CTG 5
CGG→CTA
Total 28
TMS stands for predicted TMS of the UapA. Nucleotide changes
are highlighted in bold.
1135Novel Elements of the UapA Specificity Filterwith the non-protonated N1 atom or the amide
(–NH2) groups of C6 or C2. The first condition is
already satisfied by several previously isolated
mutations, such as those concerning Q113 (TMS1–
TMS2 loop), T526 or F528 (TMS12).10 These mutants
grow equally well with uapA+ strains on standard
uric acid and xanthine concentrations (N0.3 mM),
but their growth on adenine or hypoxanthine
necessitates higher concentrations (N1–2 mM) be-
cause the relevant binding affinities are very low
(see Fig. 1b, left panel). Using one of these mutants
(UapA-F528S), we wanted to obtain second-site
mutations that will allow improved growth on
lower concentrations (0.5 mM) of adenine. An
additional prerequisite for this scheme was that
the original mutant strain used should lack all other
carriers that are able to transport adenine. This
strain was made by introducing, through transfor-
mation, the uapA-F528S allele in a genetic back-
ground lacking all endogenous transporters
mediating adenine transport (ΔuapC ΔazgA
ΔfcyB)19 (see Materials and Methods). UapA-F528S
was selected among all available specificity mutants
that perform very low-affinity adenine transport
because it was the only one that in the ΔuapC ΔazgA
ΔfcyB background showed practically no growth on
adenine at concentrations b1 mM (see Fig. 1b). UV
mutagenesis of the UapA-F528S/ΔazgA ΔfcyB
ΔuapC strain and selection for growth on 0.5 mM
adenine as sole nitrogen source led to the isolation
of 65 mutants.
Molecular and functional characterization of
UapA mutants
After purification, all mutants were tested on
various purines as nitrogen sources. All were
capable of growth in all purines, at both 25 and
37 °C (not shown). The uapA open reading frame
(ORF) of 28 of them was obtained by PCR and
sequenced. In all cases, a single base substitution,
besides the original F528S mutation, was detected
within the uapA ORF (Table 1). The 28 mutations
corresponded to 8 amino acid substitutions (Fig.
1a and Table 1). The great majority (71.4%)
involved substitutions of R481, a residue located
in the putative short loop linking TMS10 and
TMS11 (Fig. 1a). Five mutations (17.1%) involved
two residues, V463 and A469, located in TMS10.
The remaining three were obtained once and
involved residues Q113 (in the TMS1–TMS2
loop), F406 (in the NAT motif in TMS8–TMS9
loop) and A441 (in TMS9). Interestingly, mutation
Q113L was also obtained previously as a mutation
conferring UapA-mediated growth on 2 mM ad-
enine. Figure 1b shows the growth phenotypes of
the 8 mutants obtained. For most of them, growth
on adenine or hypoxanthine was stronger at 2 mM
compared with that at 0.5 mM, whereas growth
on uric acid and xanthine was identical in the
range 0.5–2.0 mM. A possible exception was
mutant A469E/F528S, which seemed to grow
significantly better than all other mutants at0.5 mM adenine. These observations suggested
that the mutants isolated might still have relatively
low affinity for purines, other than the physiolog-
ical substrates of UapA.
Uptake studies showed that all mutants have a
very similar capacity for 3H-labelled xanthine influx
compared with the UapA+ wild-type control
(Fig. 1c). These activities were dependent on the
H+ gradient of the plasma membrane, as evidenced
from the transport inhibition by H+ gradient
uncouplers (not shown). However, no measurable
uptake of radiolabelled hypoxanthine was obtained
(not shown). This apparent paradox of no detectable
hypoxanthine uptake in mutants able to grow on
this purine has also been obtained with several
previously isolated mutants. These mutants were
shown to exhibit very low hypoxanthine or adenine
binding affinities (KiN2 mM), and thus it is
technically impossible to detect hypoxanthine or
adenine uptake in standard assays performed with
concentrations of 0.2–2.0 μΜ radiolabelled
purines.9,10 Similarly, the very low affinity of the
novel mutants for purines other than uric acid or
xanthine was confirmed by measuring Ki values of
purines, pyrimidines and analogues (see below).
Thus, the transport profile of all new isolates is
typical of UapA mutants with relaxed specificity,
exhibiting high-capacity transport but very low
binding affinities for purines other than xanthine
or uric acid.
Substrate binding profile of UapA mutants
A detailed kinetic profile, reflected in Km/i values,
was established as previously described (see Mate-
rials and Methods) for all eight new mutations
(Table 2). All mutations affected little the affinity
of UapA for uric acid or xanthine (Km/i values of
0.8–15 μΜ) compared with either the wild-type
protein or the original UapA-F528S mutant (Km/I of
3–11 μΜ). Mutations of R481 had the strongest effect
as reflected in Km/i values for uric acid or xanthine
reduced by 2- to 12-fold. Several mutants also
showed a minor increase (up to 4-fold) in affinity
for adenine, hypoxanthine or guanine compared
with the original F528S strain, but their actual
Table 2. Substrate binding profile of specificity mutants obtained in F528S genetic background
Κm/i (μΜ)
Substrate/ligand UapA+ F528S
Q113L/
F528S
F406Y/
F528S
A441V/
F528S
V463I/
F528S
A469E/
F528S
R481G/
F528S
R481L/
F528S
R481Q/
F528S
Xanthine 8 3 3 1.3 6 13 1.5 1.6 1.0 0.8
Uric acid 7 11 4 6 15 12 2 0.9 1.4 1.3
Adenine NI NI ∼2000 ∼2000 ∼1800 NI ∼2000 NI NI NI
Hypoxanthine NI ∼2000 ∼1500 ∼2000 ∼1100 NI ∼1800 ∼2000 ∼1600 ∼1600
Guanine NI ∼2000 982 ∼1000 500 NI 500 NI NI NI
Uracil NI ∼2000 77 322 123 386 127 75 113 35
1-Methyl-xanthine 280 420 820 ∼1000 88 ∼1000 300 247 851 151
2-Thio-xanthine 63 63 16 59 20 38 100 10 12 8
3-Methyl-xanthine 28 24 5 7 10 57 30 14 3 4
6-Thio-xanthine 350 92 9 50 22 56 20 13 4 8
7-Methyl-xanthine NI ∼1000 46 274 92 210 88 89 115 48
8-Methyl-xanthine 100 45 8 9 10 33 10 9 7 4
9-Methyl-xanthine 200 345 452 302 662 ∼1000 ∼1000 ∼1000 NI 161
Oxypurinol 100 45 6 25 9 31 22 3 3 10
Km/i values were determined as described in Materials and Methods. NI indicates no inhibition (90%–100% uptake). The ‘∼’ symbol
stands for values N1000 μM that were approximately estimated. Results are averages of at least three independent experiments with three
replicates for each concentration point. Standard deviation was b20%.
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(Km/iN500 μΜ). This was in agreement with growth
tests showing that full growth on adenine or
hypoxanthine was only achieved at 2 mM. These
results show that the mutants isolated have an
increased capacity for adenine or hypoxanthine
accumulation and most probably for several other
nucleobases, which, however, is not due to a
significant increase in corresponding binding affin-
ities. This is highlighted mostly in mutants of R481,
which show no or very little measurable affinity for
these purines despite growing strongly on adenine
or hypoxanthine (Table 2).
Interestingly, all mutants showed a tendency of
increased binding affinities for uracil, oxypurinol
and several xanthine analogues with bulky sub-
stitutions at positions 2, 3, 7 and 8. None of
the mutations, however, increases the affinity of
UapA for analogues substituted at positions N1
and N9, which are proposed to be absolutely
critical for direct interactions with the substrate
binding site10 (Table 2). Among all mutants, those
concerning R481 showed the highest increase in
UapA affinities for uracil, oxypurinol and bulky
xanthine analogues. This picture not only sup-
ported the proposed model on the importance of
the different positions in the purine ring for
binding to the substrate pocket but also resembled
the effect of previously isolated specificity muta-
tions mapping in the TMS1–TMS2 loop and in
TMS12.2,3,9,10
Additive effects of novel mutations and F528S
We constructed by genetic transformation strains
expressing the novel uapA mutation alleles in the
absence of F528S. In all new strains, uapA alleles
were expressed from their endogenous promoter
from plasmids integrated in single or multiple
copies (see Materials and Methods). Figure 2 and
Table 3 show the analysis of these strains. In theabsence of F528S, all mutants, in single- or multiple-
copy plasmid versions, showed nearly wild-type
growth on uric acid or xanthine, similar to that also
obtained in the presence of F528S. In contrast,
growth on other purines was significantly different
from that obtained in the presence of F528S. In
particular, all mutants arising from single-copy
plasmid integration, besides A441V, retained very
little or even lost the ability for growth on 0.5 mM
adenine or hypoxanthine. In some mutants, but not
those concerning R481 and A441, growth on adenine
or hypoxanthine was stronger in multiple-copy
plasmid mutants. Most single-copy plasmid
mutants, besides F406Y and V463I, could grow
well, similar to F528S, at elevated adenine or
hypoxanthine concentrations (2 mM). The F406Y
and V463I mutants were also more resistant to
oxypurinol, resembling a control strain lacking
UapA activity.
Uptake studies showed that none of the mutations
significantly affected UapA-mediated, H+-dependent
transport of 3H-labelled xanthine (Fig. 2b and not
shown). Furthermore, no measurable uptake of
radiolabelled hypoxanthine was obtained (not
shown), predicting that all single mutants exhibit
very low binding affinities for purines other than
their natural substrates. This was confirmed by
directly measuring Ki values of purines, pyrimidines
and analogues. Table 3 shows the substrate binding
profile of the novel mutants established in the
absence of F528S. It was clear that this is different
from the one obtained in the genetic background of
the F528S mutation. Affinities for xanthine and uric
acid were close to that of the wild-type protein (2- to
3-fold differences), with the exception of V463I and
R481Q, which have Km values for xanthine reduced
by 6- and 9-fold, respectively, and A469E, which has
a Ki value for uric acid increased by 8-fold. A very
moderate increase in the affinity for adenine was
obtained only for some mutants (V463I, A469E),
whereas there is a stronger and more general trend
Fig. 2. (a) Growth tests of the novel mutations in the
absence of the original substitution on different purines as
nitrogen sources. Control strains and growth conditions
are described in Fig. 1b. (b) Relative 3H-labelled xanthine
transport rates of single-copy novel mutations expressed
as percentage of initial uptake rates (V) compared with the
wild-type (UapA+) rate, as described in Fig. 1c.
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thine, guanine, uracil and xanthine analogues with
bulky substitutions at positions 2, 3, 7 and 8, but not
for analogues substituted at positions 1 and 9. Forseveral mutants, this increase was smaller than that
observed in the F528S genetic background. On the
whole, however, affinities for purines other than
uric acid and xanthine remain very low (N700 μM),
in agreement with the observation that all single-
copy plasmid mutants, besides A441V, could only
grow well on adenine or hypoxanthine at 2 mM (see
Fig. 2). The only notable exception was mutant
A441V, which showed a rather moderate affinity for
hypoxanthine (260 μΜ) that could in principle
partially explain growth on 0.5 mM hypoxanthine.
However, the same mutant has no detectable
affinity for adenine, despite its ability to grow on
this purine at 0.5 mM, prompting us to believe that,
even in that case, growth on purines other than uric
acid or xanthine is due to increased capacity of
transport per se, rather than increased substrate
binding affinities (see later).
Functional consequences of mutations affecting
the TMS10–TMS11 loop
To further investigate the role of the TMS10–
TMS11 loop and in particular that of residue R481,
we followed a dual approach: First, we constructed
double mutants by combining a selected mutation
in R481 (R481G) with other mutations affecting
UapA specificity, located in the TMS1–TMS2 loop
(Q113L) or in TMS12 (T526M). Second, we made
two UapA mutations that either delete R481
(ΔR481) or relocate its position within the TMS10–
TMS11 loop by introducing two small and flexible
amino acid residues (Ala–Gly) just upstream from it
(AGR481).
The double mutants Q113L/R481G and R481G/
T526M showed growth phenotypes very similar to
R481G/F528S (i.e., they can grow on low adenine or
hypoxanthine concentration; Fig. 3). This suggested
that the effects of R481G and Q113L or T526M are
additive, similar to R481G and F528S. The additive
effect of R481G with all three previously described
mutations affecting UapA specificity was also
reflected in substrate binding affinities. Table 4
shows that the binding affinities for most purines of
Q113L/R481G, and especially R481G/T526M, were
significantly increased compared with the single
mutants. More specifically, R481G/T526M shows
high affinity for uracil (32 μΜ), moderate affinity for
hypoxanthine and guanine (179–225 μΜ) and the
highest affinity, albeit still low, for adenine
(∼1 mM), among all mutants described herein and
previously. It also has increased affinity for xan-
thine, oxypurinol and nearly all xanthine analogues
tested, with 9-methyl-xanthine being a notable
exception.
The ΔR481 and AGR481 mutations inactivated
UapA function, as the corresponding mutants could
not grow in any purine as sole nitrogen source (Fig.
3a). To investigate the basis of phenotype, we
analysed these mutants by making use of a GFP
tag (addition of GFP at the C-terminus of UapA has
no effect on UapA subcellular expression or on its
function20). Figure 3b shows that in both mutants,
Table 3. Substrate binding profile of specificity mutants in the absence of F528S
Κm/i (μΜ)
Substrate/ligand UapA+ Q113L F406Y A441V V463I A469E R481G R481L R481Q
Xanthine 8 4 3 4 1.3 8.5 18 3 0.9
Uric acid 7 10 11 10 12 58 19 6 3.5
Adenine NI NI NI NI ∼1700 ∼1500 NI NI ∼2500
Hypoxanthine NI 260 ∼2000 260 900 880 NI NI ∼1000
Guanine NI ∼1000 ∼2000 NI 750 NI NI NI ∼700
Uracil NI 413 ∼2000 413 268 380 ∼1000 NI ∼1200
1-Methyl-xanthine 280 280 420 280 300 500 200 150 200
2-Thio-xanthine 63 10 63 10 60 280 90 43.1 10.1
3-Methyl-xanthine 28 9 24 9 7 32.1 27 18.5 5.1
6-Thio-xanthine 350 38 92 38 132 300 56.6 59.1 3.7
7-Methyl-xanthine NI ∼1000 ∼1000 ∼1000 270 690 140 65.3 41.3
8-Methyl-xanthine 100 110 45 110 100 61 100 10 2.5
9-Methyl-xanthine 200 NI 345 NI 379 NI 124 286 200
Oxypurinol 100 29 8.2 14.4 96.5 18.4 14.3 14.4 25.8
For details, see Table 2.
1138 Novel Elements of the UapA Specificity FilterUapA-GFP molecules label vacuolar lumens or
other internal structures but not the plasma mem-
brane—a picture characteristic of misfolded orFig. 3. (a) Growth tests of the constructed mutations on d
growth conditions are described in Fig. 1b. (b) Epifluoresce
AGR481 and ΔR481 mutants. Strains were grown as described
expressed in the plasma membrane and appeared mostly at t
single copy (ΔR481-sc) or multiple copies (ΔR481-mc) of the mextremely unstable transporters. The simplest ex-
planation of this result is that altering the length of
the TMS10–TMS11 loop destabilizes UapA.ifferent purines as nitrogen sources. Control strains and
nce microscopy of a wild-type (UapA-GFP) control and
by Koukaki et al.7 In all mutant strains, UapA was weakly
he vacuoles. For ΔR481, two strains are shown carrying a
utated allele. All images have the same magnification.
Table 4. Substrate binding profile of rationally designed double mutations
Κm/i (μΜ)
Substrate/ligand UapA+ Q113L R481G T526Ma Q113L/R481G R481G/T526M
Xanthine 8 8 18 5 1.3 1.2
Uric acid 7 7 19 12 2.5 8
Adenine NI NI NI ∼2500 NI 980
Hypoxanthine NI NI NI ∼1700 1300 179
Guanine NI NI NI ND NI 225
Uracil NI NI ∼1000 76/N1000 536 32
1-Methyl-xanthine 280 280 200 288 ∼300 ∼40
2-Thio-xanthine 63 63 90 8 17 13
3-Methyl-xanthine 28 28 27 11 8 5.5
6-Thio-xanthine 350 350 57 6 4.5 4
7-Methyl-xanthine NI NI 140 ∼1000 NI 361
8-Methyl-xanthine 100 100 100 6 4 4
9-Methyl-xanthine 200 200 124 202 NI ∼1000
Oxypurinol 100 29 14 22 11 2
For details, see Table 2. ND indicates not determined.
a Papageorgiou et al.10
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UapA mutants with increased transport capacity
for non-physiological substrates
Our original goal was to design and test a direct
genetic screen for obtaining UapA mutations
conferring a specific increase in adenine affinity.
Considering that adenine has a pyrimidine moiety
very distinctive from that of other purines, we
reasoned that such mutations would lead us to the
identification of amino acid residues, within the
UapA substrate binding pocket, that could directly
interact with the so-called amidine group. Our
results show that instead of isolating mutants with
increased affinity specifically for adenine, we
obtained mutations that increase the accumulation
of purines other than the physiological substrates of
UapA. As this increase concerns solely the trans-
port of purines other than uric acid or xanthine,
it cannot be due to an increase in the amount of
permease present in the plasma membrane. This
in turn suggests that the novel mutations increase
the bona fide transport capacity of UapA specifically
for purines that cannot be transported by the wild
type or the F528S version of UapA. Importantly,
despite a moderate increase in the binding of
hypoxanthine or guanine conferred by mutations,
all novel mutants still retain low affinities for
purines (N260 μM) other than uric acid or xanthine,
independently of the presence of mutation F528S.
Particularly for adenine, all mutants showed very
low binding affinities (N1.5 mM). This observation
further supports the idea that the novel mutations
lead to increased intrinsic transport capacity of
UapA, specifically for purines other than uric
acid or xanthine, rather than increased relative
binding affinities. In that sense, the novel muta-
tions are very similar to previously characterized
substitutions located in TMS12 and in the TMS1–
TMS2 loop.Residues in TMS9 and TMS10 might line the
substrate translocation pathway
Unlike mutations concerning Q113, F406 and
R481, which map in putative loops and have a
pronounced effect on UapA transport specificity
particularly in the presence of the F528S substitu-
tion, mutations A441V, V463I and A469E map in
TMSs and seem to affect UapA transport specificity
even in the absence of mutation F528S (compare
growth on 0.5 mM adenine in Figs. 1 and 2). This is
evident in mutants arising from multiple-copy
plasmid integrations, but at least for A441V, this is
also apparent in single-copy transformants (see
growth on 0.5 mM adenine in Fig. 2). Furthermore,
these mutations also lead to more drastic increases
in the binding affinities of several nucleobases in the
absence of mutation F528S, rather than in its
presence (compare values in Tables 3 and 4). Despite
an apparent additive effect of mutations in TMS10
(V463I or A469E) with F528S on the capacity of
UapA to transport adenine or hypoxanthine, the
effect of TMS9 or TMS10 mutations is not additive
with that of F528S with respect to UapA specificity.
These observations suggest that residues in TMS9 or
TMS10 act independently to contribute in substrate
specificity. Given their nature, we can speculate that
the corresponding mutated residues contribute
through specific van der Waals forces to the
progressive sliding or fitting of purines within the
substrate translocation pathway. Support for this
comes from comparison with other NATs of known
specificities. The residue corresponding to V463 in
other NAT members is either a Val or an Ile, which,
together with the mutation isolated in UapA
(V463I), shows that these amino acids might be the
only functionally permissive residues at this posi-
tion. Residue A469 is more variable, being replaced
in other NATs by Arg, Ser or Lys. Interestingly,
NAT homologues with no (e.g., bacterial members
Ygfo, YicE and PbuX) or moderate (e.g., UapC of A.
nidulans and Aspergillus fumigatus or Xut1 of Candida
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residue. The possible contribution of Ala469 in uric
acid binding in UapA is supported by the fact that
mutation A469E significantly affects (8.5-fold reduc-
tion) uric acid binding (see Table 3). Finally, A441 is
relatively well conserved, although some NAT
members have other small amino acid residues at
this position (Gly, Ser, Thr, Pro). The role of the
above residues on UapA function could not have
been predicted by a rational design of mutations.
Synergy of loops TMS1–TMS2, TMS8–TMS9 and
TMS12 determines UapA specificity
We have previously provided evidence that very
fine interactions between the TMS8–TMS9 loop,
hosting basic elements of the substrate translocation
pathway, and the TMS1–TMS2 loop or TMS12, two
regions affecting substrate specificity, define the
function of UapA, particularly with respect to
substrate selection and binding affinity. Here, we
obtained new unbiased evidence that TMS12 inter-
acts functionally with the TMS8–TMS9 and TMS1–
TMS2 loops. Mutations Q113L (TMS1–TMS2 loop)
and F406Y (in the NAT motif in TMS8–TMS9 loop)
promote increased transport capacity for adenine,
hypoxanthine and probably other several nucleo-
bases only when combined with F528S (TMS12). The
additive phenotypes of these mutations are also
reflected in differences in the Km/i values for several
nucleobases (e.g., xanthine, uric acid, guanine, uracil)
and nucleobase analogues. These results confirm that
substitutions in these three domains additively
inactivate the synergistic interactions responsible for
the high substrate specificity of UapA.
Dynamic elements at both sides of UapA
selectively control the accessibility of sub-
strates to their translocation pathway
The great majority of mutants (20 of 28, ∼72%)
selected in the background of F528S concerned
residue R481, located in the short putative cytoplas-
mic loop that links TMS10 with TMS11. This arginine
residue is conserved only in fungal homologues,
whereas in bacterial, plant and animalNATmembers,
it is replaced by Leu, Ile, Thr or Lys. Interestingly, in
the homologous mammalian NATs, the residues
corresponding to UapA R481 are leucines, irrespec-
tive of whether they are specific for ascorbate (SVCT1
and SVCT2)2,13 or nucleobases (rSNBT).14 However,
none of the mutations of R481, including R481L,
conferred to UapA a detectable binding affinity for
ascorbate (data not shown). The lack of evolutionary
conservation at this position is in line with the
observation that mutants with variable substitutions
all proved functional. This suggests that R481 might
be involved in a fine topological interaction specifi-
cally narrowing the selectivity of UapA. Positive
cytoplasm-facing residues are believed to play im-
portant topological roles in several membrane pro-
teins through their interaction with negatively
charged lipids of the inner leaflet of the plasmamembrane.21 Alternatively, R481 might interact with
a negatively charged residue of UapA and thus create
a specific bridge that blocks the passage of purines
other than uric acid or xanthine. Interestingly,
mutations that delete R481 or affect the length, and
apparently the flexibility, of the TMS10–TMS11 loop
lead to unstable non-functional UapA molecules that
are rapidly turned over. In any way, this short loop
seems to act as a key element in the dynamic
positioning of the TMS10 and TMS11 α-helices and
thus for the selection and translocation of specific
substrates through UapA.
The putative inward-facing topology of R481 and
the additive nature of R481 substitutions with
mutations located toward the extracytoplasmic face
of the transporter, which also reduce specificity,
strongly suggest that UapA has molecular determi-
nants acting as selective gates at both sides of the
plasma membrane. Gating is a term used mostly for
channels and usually implies the dynamic action of
domains or some amino acid residues, triggered
through either ligand binding or a change in voltage,
which allows or restricts the passage of ions through a
rather rigid and continuous transmembrane pore. For
transporters, the dogma is that they do not form a
continuous pore and thus do not use a gating
mechanism. They rather exist in at least two alternat-
ing conformations, making them accessible to sub-
strates either intracellularly or extracellularly, through
a rocker-switch mechanism. In fact, it is probably the
binding of substrates that allosterically promotes the
alternation of the different conformers. In the last
2 years, however, a number of crystal structures of
evolutionary and functionally distinct transporters
confirmed the existence of domains or loops at both
sides of the plasma membrane that occlude or open
the access of substrates to the sensu stricto binding
site.22–28 Our results provide strong functional evi-
dence for the existence of such dynamic domains or
amino acids, distinct from the substrate binding site,
that are implicated in subtle movements determining
the function and specificity of a transporter.Materials and Methods
Media, strains, growth conditions and
transformation genetics
Standard media for A. nidulans and E. coli were used.29
The ΔuapA ΔuapC ΔazgA ΔfcyB pabaA1 strain (ΔUapA)
carrying a single-copy integration of the uapA (UapA+) was
a standard wild-type control. The strain used to select the
original mutants was a ΔuapA ΔuapC ΔazgA ΔfcyB pabaA1
(ΔUapA) carrying a single-copy integration of the uapA-
F528S (F528S).10 pabaA1 is a genetic auxotrophy for p-
aminobenzoic acid. UV mutagenesis was as described
previously.6 An isogenic ΔuapA ΔuapC ΔazgA ΔfcyB
pabaA1mutant was the recipient strain in transformations30
with uapA alleles cloned in vector pAN520exp31 or with an
‘empty’ vector as a negative control. These vectors allow
selection of transformants based on p-aminobenzoic acid
auxotrophy complementation. Transformants expressing
intact uapA or uapA-gfp alleles, through either single- or
1141Novel Elements of the UapA Specificity Filtermultiple-copy plasmid integration events, were identified
by PCR and Southern analysis. In most cases, we selected
transformants originating from homologous integration in
the pabaA locus. In some cases, single-copy uapA alleles
were integrated heterologously, but these transformants
expressed UapA also at physiological levels (not shown).
Growth tests were performed at 25 and 37 °C and at
different purine concentrations (0.5 and 2 mM): 0.5 mM is
the standard purine concentration used in all previous
studies concerning purine metabolism in A. nidulans.
Oxypurinol was used at 100 μM, with nitrate (10 mM) as
a nitrogen source. uapA alleles resulted in phenotypes that
were independent of the presence or absence of the C-
terminal gfp epitope.20
Plasmid constructions and uapA mutations
pAN510 is a pBlueScript vector carrying a uapA fusion
with its flanking sequences and the argB gene as a selection
marker.20 pAN510-GFP is a pBlueScript vector carrying a
uapA-gfp fusion with its flanking sequences and the argB
gene as a selection marker.20 pAN510exp is a modified
version of pAN510, introducing a BamHI site at the
translation start codon and knocking out an XbaI site in the
pBlueScript multicloning region for cloning purposes.19
pAN520exp is a modified version of pAN510exp, replacing
the auxotrophicmarker argBwith pabaA at the SalI site of the
plasmid. The uapA ORF from the original mutants was
amplified by PCR using primers 5′-cgggatccctccatccattcaacc-
gac-3′ and 5′-gctctagactaagcctgcttgctctgatac-3′, cloned in
pAN510exp and sequenced†. Mutations ΔR481 and
AGR481 were constructed by site-directed mutagenesis
according to the QuikChange® Site-Directed Mutagenesis
Kit (Stratagene) on vector pAN510-GFP using complemen-
tary oligonucleotides carrying the desired substitution
(forward primers: 5′-ccgttcacaaggcgaaatgccggccggtttatcct-
caccgcg-3′ and 5′-gcgccgttcacaaggcgaaattttatcctcaccgcgt-
caatg-3′, respectively) and confirmed by sequencing. The
uapA-gfp fusion was amplified by PCR, using primers 5′-
cgggatccctccatccattcaaccgac-3′ and 5′-cgtctagattacttgta-
cagctcgtcc-3′, and subsequently cloned in pAN520exp.
Finally, the constructed plasmids were introduced by
transformation into a ΔuapA ΔuapC ΔazgA ΔfcyB pabaA1
strain, and the resulting integration events were subjected to
Southern analysis.32 Single mutations F406Y, A441V, V463I,
A469E, R481Q, R481L and R481G were constructed by
replacing the SacI/SacI fragment from each double mutant
with the corresponding fragment of pAN510exp. Q113L/
R481Gwas constructed by replacing theClaI/XbaI fragment
of pAN510expUapA-R481G with the corresponding frag-
ment from pAN510expUapA-Q113L, containing the Q113L
mutation. R481G/T526M was constructed by replacing the
SacI/SacI fragment of pAN510expUapA-T526M with the
corresponding fragment from pAN510expUapA-R481G,
containing the R481G mutation. In all cases, the uapA ORF
was amplified by PCR using the primers 5′-cgggatccctccatc-
cattcaaccgac-3′ and 5′-gctctagactaagcctgcttgctctgatac-3 and
subsequently cloned in pAN520exp.
Standard nucleic acid manipulations and
fluorescence microscopy
Southern blot and PCR analyses were performed as
described by Sambrook et al.32 [32P]dCTP-labelled mole-
cules used as pabaA- or uapA-specific probes were prepared†http://www.macrogen.comusing a random hexanucleotide primer kit following the
supplier's instructions (Takara, Japan). Labelled [32P]dCTP
(3000 Ci/mmol) was purchased from the Institute of
Isotopes Co., Ltd. Total genomic DNA isolation from A.
nidulans strains and all other techniques involving DNA
manipulationswere described by Sambrook et al.32 Samples
for fluorescence microscopy were prepared as described
previously.20 In brief, the samples were incubated on
coverslips in liquid minimal medium29 supplemented with
urea as nitrogen source at 25 °C for 12–14 h, observed on an
Axioplan Zeiss phase-contrast epifluorescence microscope
with appropriate filters, and the resulting images were
acquired with a Zeiss MRC5 digital camera using the
AxioVs40 V4.40.0 software. Images were then processed in
Adobe Photoshop CS2 V9.0.2 software.
Kinetic analysis
Radiolabelled purines (19.6–33.4 Ci/mmol) were from
Moravek Biochemicals (Brea, CA). 3H-labelled xanthine or
hypoxanthine uptake was assayed in conidiospores at 37
or 25 °C as described previously.5 All experiments were
carried out in triplicate. Initial velocities were corrected by
subtracting background uptake values, measured in the
azgA−uapA−uapC−fcyB− mutant. Km (concentration for
obtaining Vm/2) and IC50 (concentration reducing 50%
of the Vm) values for compounds inhibiting the uptake of
radiolabelled permeants (xanthine or hypoxanthine) were
determined from full dose–response curves with a
minimum of eight points spread over the relevant range.
In all cases, the Hill coefficients were close to −1,
consistent with competitive inhibition. Ki values were
calculated from the Cheng and Prusoff equation, Ki= IC50/
[1+(L/Km)], in which L is the permeant concentration.
33
Speculative UapA topology
Speculative UapA topology was based on several
standard algorithms (PredictProtein, HHpred, TMHMM,
SOSUI, TMAP, TopPred, etc.), the ConSeq program‡ and
minor manual modifications depending on the presence of
Pro residues and the ‘positive-inside rule’21 at the borders of
putative helices. All algorithms predict as α-helical trans-
membrane domains the segments shown in Fig. 1 as TMS1–
TMS8 andTMS12.Most algorithms also predict the TMS9b–
TMS11 shown in Fig. 1. Some algorithms predict an extra
TMS, which here we call TMS9a (horizontal cylinder in Fig.
1), in the segment between TMS8 and TMS9b. Based on the
above and the substituted-cysteine accessibility method
performed in YgfO, which shows that TMS9a has extended
parts accessible to hydrophilic reagents (see the text), we
propose that this segment is a flexible dynamic domain or a
reentrant loop that acquires alternative topology during
substrate binding and transport.Acknowledgements
Work in the laboratory of G.D. was partly
supported by the University of Athens (ELKE). We
are grateful to S. Amillis for helping in the
preparation of the manuscript and for discussions.‡http://conseq.tau.ac.il/
1142 Novel Elements of the UapA Specificity FilterReferences
1. Gorfinkiel, L., Diallinas, G. & Scazzocchio, C. (1993).
Sequence and regulation of the uapA gene encoding a
uric acid–xanthine permease in the fungus Aspergillus
nidulans. J. Biol. Chem. 268, 23376–23381.
2. Gournas, C., Papageorgiou, I. & Diallinas, G. (2008).
The nucleobase-ascorbate transporter (NAT) family:
genomics, evolution, structure–function relationships
and physiological role. Mol. BioSyst. 4, 404–416.
3. Diallinas, G. & Gournas, C. (2008). Structure–function
relationships in the nucleobase-ascorbate transporter
(NAT) family: lessons from model microbial genetic
systems. Channels (Austin), 2, 363–372.
4. Diallinas, G., Valdez, J., Sophianopoulou, V., Rosa,
A. & Scazzocchio, C. (1998). Chimeric purine
transporters of Aspergillus nidulans define a domain
critical for function and specificity conserved in
bacterial, plant and metazoan homologues. EMBO
J. 17, 3827–3837.
5. Meintanis, C., Karagouni, A. D. & Diallinas, G. (2000).
Amino acid residues N450 andQ449 are critical for the
uptake capacity and specificity of UapA, a prototype
of a nucleobase-ascorbate transporter family. Mol.
Membr. Biol. 17, 47–57.
6. Amillis, S., Koukaki, M. & Diallinas, G. (2001).
Substitution F569S converts UapA, a specific uric
acid–xanthine transporter, into a broad specificity
transporter for purine-related solutes. J. Mol. Biol. 313,
765–774.
7. Koukaki, M., Vlanti, A., Goudela, S., Pantazopoulou,
A., Gioule, H., Tournaviti, S. & Diallinas, G. (2005).
The nucleobase-ascorbate transporter (NAT) signa-
ture motif in UapA defines the function of the purine
translocation pathway. J. Mol. Biol. 350, 499–513.
8. Pantazopoulou, A. & Diallinas, G. (2006). The first
transmembrane segment (TMS1) of UapA contains
determinants necessary for expression in the plasma
membrane and purine transport.Mol. Membr. Biol. 23,
337–348.
9. Vlanti, A., Amillis, S., Koukaki, M. & Diallinas, G.
(2006). A novel-type substrate-selectivity filter and
ER-exit determinants in the UapA purine transporter.
J. Mol. Biol. 357, 808–819.
10. Papageorgiou, I., Gournas, C., Vlanti, A., Amillis, S.,
Pantazopoulou, A. & Diallinas, G. (2008). Specific
interdomain synergy in the UapA transporter deter-
mines its unique specificity for uric acid among NAT
carriers. J. Mol. Biol. 382, 1121–1135.
11. Goudela, S., Karatza, P., Koukaki, M., Frillingos, S. &
Diallinas, G. (2005). Comparative substrate recogni-
tion by bacterial and fungal purine transporters of the
NAT/NCS2 family. Mol. Membr. Biol. 22, 263–275.
12. Argyrou, E., Sophianopoulou, V., Schultes, N. &
Diallinas, G. (2001). Functional characterization of a
maize purine transporter by expression in Aspergillus
nidulans. Plant Cell, 13, 953–964.
13. Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger,
U. V., Chen, X. Z., Wang, Y. et al. (1999). A family
of mammalian Na+-dependent L-ascorbic acid
transporters. Nature, 399, 70–75.
14. Yamamoto, S., Inoue, K., Murata, T., Kamigaso, S.,
Yasujima, T., Maeda, J. Y., et al. (in press). Identifica-
tion and functional characterization of the first
nucleobase transporter in mammals: implication in
the species difference in the intestinal absorption
mechanism of nucleobases and their analogs between
higher primates and other mammals J. Biol. Chem.,
doi/10.1074/jbc.M109.032961.15. Karatza, P. & Frillingos, S. (2005). Cloning and
functional characterization of two bacterial members
of the NAT/NCS2 family in Escherichia coli. Mol.
Membr. Biol. 22, 251–261.
16. Karatza, P., Panos, P., Georgopoulou, E. & Frillingos,
S. (2006). Cysteine-scanning analysis of the nucleo-
base-ascorbate transporter signature motif in YgfO
permease of Escherichia coli: Gln-324 and Asn-325
are essential, and Ile-329–Val-339 form an alpha-helix.
J. Biol. Chem. 281, 39881–39890.
17. Papakostas, K., Georgopoulou, E. & Frillingos, S.
(2008). Cysteine-scanning analysis of putative helix
XII in the YgfO xanthine permease: ILE-432 and
ASN-430 are important. J. Biol. Chem. 283,
13666–13678.
18. Karena, E. & Frillingos, S. (2009). Role of intramem-
brane polar residues in the YgfO xanthine permease:
HIS-31 and ASN-93 are crucial for affinity and
specificity, and ASP-304 and GLU-272 are irreplace-
able. J. Biol. Chem. 284, 24257–24268.
19. Vlanti, A. & Diallinas, G. (2008). The Aspergillus
nidulans FcyB cytosine–purine scavenger is highly
expressed during germination and in reproductive
compartments and is downregulated by endocytosis.
Mol. Microbiol. 68, 959–977.
20. Pantazopoulou, A., Lemuh, N. D., Hatzinikolaou, D.
G., Drevet, C., Cecchetto, G., Scazzocchio, C. &
Diallinas, G. (2007). Differential physiological and
developmental expression of the UapA and AzgA
purine transporters in Aspergillus nidulans. Fungal
Genet. Biol. 44, 627–640.
21. vonHeijne, G. & Gavel, Y. (1988). Topogenic signals in
integral membrane proteins. Eur. J. Biochem. 174,
671–678.
22. Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. &
Gouaux, E. (2005). Crystal structure of a bacterial
homologue of Na+/Cl−-dependent neurotransmitter
transporters. Nature, 437, 215–223.
23. Faham, S., Watanabe, A., Besserer, G. M., Cascio, D.,
Specht, A., Hirayama, B. A. et al. (2008). The crystal
structure of a sodium galactose transporter reveals
mechanistic insights into Na+/sugar symport. Science,
321, 810–814.
24. Weyand, S., Shimamura, T., Yajima, S., Suzuki, S.,
Mirza, O., Krusong, K. et al. (2008). Structure and
molecular mechanism of a nucleobase-cation-
symport-1 family transporter. Science, 322, 709–713.
25. Singh, S. K., Piscitelli, C. L., Yamashita, A. & Gouaux,
E. (2008). Antidepressant binding site in a bacterial
homologue of neurotransmitter transporters. Science,
322, 1655–1661.
26. Diallinas, G. (2008). Biochemistry. An almost-complete
movie. Science, 322, 1644–1645.
27. Fang, Y., Jayaram, H., Shane, T., Kolmakova-
Partensky, L., Wu, F., Williams, C. et al. (2009).
Structure of a prokaryotic virtual proton pump at
3.2 Å resolution. Nature, 460, 1040–1043.
28. Gao, X., Lu, F., Zhou, L., Dang, S., Sun, L., Li, X. et al.
(2009). Structure and mechanism of an amino acid
antiporter. Science, 324, 1565–1568.
29. Cove, D. J. (1966). The induction and repression of
nitrate reductase in the fungus Aspergillus nidulans.
Biochim. Biophys. Acta, 113, 51–56.
30. Koukaki, M., Giannoutsou, E., Karagouni, A. &
Diallinas, G. (2003). A novel improved method for
Aspergillus nidulans transformation. J. Microbiol.
Methods, 55, 687–695.
31. Gournas, C., Amillis, S., Vlanti, A. & Diallinas, G.
(2009). Transport-dependent endocytosis and
1143Novel Elements of the UapA Specificity Filterturnover of a uric acid–xanthine permease. Mol.
Microbiol. 75, 246–260.
32. Sambrook, J., Fritsch, E. & Maniatis, T. (1989).
Molecular Cloning: A Laboratory Manual. Cold Spring
Harbor Press, Cold Spring Harbor, NY.33. Cheng, Y. & Prusoff, W. H. (1973). Relationship
between the inhibition constant (K1) and the concen-
tration of inhibitor which causes 50 per cent inhibition
(I50) of an enzymatic reaction. Biochem. Pharmacol. 22,
3099–3108.
